Bristol Myers Squibb in Cambridge, MA seeks a Director of Bioconjugation to shape the strategic direction for antibody-based conjugates. You will lead a team of bioconjugation scientists and partner with Chemistry on linker-payload design across ADC/ARC portfolios, building platform capabilities to support target nomination and development transitions.
The role requires extensive leadership, deep bioconjugation chemistry expertise, and collaboration across biology, DMPK, toxicology, and
#J-18808-Ljbffr